Sign In
Buy MRNA
$47.44
-4.15 (-8.04%)
At Close: Jun 05, 2026
Report of new COVID wave in China pushes shares of vaccine makers higher
05:32pm, Tuesday, 23'rd May 2023
Dr. Kavita Patel, fmr. White House health policy director, joins 'Fast Money' to discuss the latest reports of a possible uptick of COVID cases in China, the immunity situation in the country, and the
Is Trending Stock Moderna, Inc. (MRNA) a Buy Now?
10:23am, Tuesday, 23'rd May 2023
Moderna (MRNA) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is Moderna Stock a Buy Now?
10:00am, Tuesday, 23'rd May 2023
Moderna's vaccine-related sales have started to decline. However, the biotech is getting closer to new approvals.
Bank Of America Upped Its Forecast For Stocks — Just Not The Ones You Think
08:00am, Tuesday, 23'rd May 2023
Bank of America is getting more bullish on S&P 500 stocks. Just not the ones that have been driving the S&P 500 higher all year.
3 Stocks You'll Be Glad You Bought at These Prices
05:30am, Tuesday, 23'rd May 2023
Moderna's respiratory vaccine business could be a major growth driver in a few years. Etsy's capital-light business model helps it generate strong levels of free cash flow.
Moderna (MRNA) Posts Upbeat Data on Protein Replacement Therapy
12:50pm, Monday, 22'nd May 2023
Interim data from a study shows that Moderna's (MRNA) investigational therapy for propionic acidemia (PA) exhibited early signs of dose-dependent pharmacology and potential clinical benefits.
Here's what Pfizer and Moderna say is next for their Covid vaccines
12:22pm, Monday, 22'nd May 2023
Pfizer and Moderna are ushering in a new era for their Covid shots that aims to simplify what people need to do to coexist with the virus.
Hero or Zero? 3 High-Risk Biotech Stocks to Make You Rich
06:40am, Monday, 22'nd May 2023
These biotech stocks are swinging for the fences. They may hit homers, they may strike out.
TipRanks reveals the top 10 health care sector analysts of the past decade
08:20am, Sunday, 21'st May 2023
TipRanks' analyst ranking service ranks the top Wall Street firms of the past decade.
Biotech Stocks Are Already Risky -- Now There Are 3 New Headwinds to Face in 2023
08:00am, Friday, 19'th May 2023
Trends in drug development are shifting quickly these days. Research and development costs for pre-clinical trials are going to rise more.
Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69%
10:07am, Thursday, 18'th May 2023
Its bottom line didn't turn red last quarter, as many investors might have been expecting. However, that doesn't mean the company is out of the woods.
3 Magnificent Growth Stocks to Buy to Help Build a Millionaire Portfolio
05:30am, Thursday, 18'th May 2023
Amazon is a leader in two high-growth industries and should benefit from that over time. Moderna aims to capture as much as half of the respiratory vaccine market later this decade.
Growth Stocks Are Back — Analysts Like These 8 The Best
08:00am, Wednesday, 17'th May 2023
Growth stocks in the S&P 500 are racing back. And analysts are scrambling to choose their favorites.
Could Latecomer Moderna Match Big Pharma Rivals in RSV?
02:00pm, Tuesday, 16'th May 2023
Moderna may be close to entering a new billion-dollar market. But it's a step behind GSK and Pfizer.
Is It Too Late to Buy Moderna Stock?
05:30am, Monday, 15'th May 2023
Demand for Moderna's billion-dollar product is falling. But the company has laid out plans to expand beyond the coronavirus vaccine -- and bring in billions from more than one product by 2027.
